Doxorubicin Hydrochloride
- Product NDC
- 0069-1442
- 11-digit product format
- 000691442
- Labeler code
- 0069
- Product ID
- 0069-1442_b4c94e1f-f7c7-4b4b-9fe2-111903c0d312
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxorubicin Hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Application
- NDA050629
- Marketing category
- NDA
- Marketing start
- 2024-10-14
- Substance
- DOXORUBICIN HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 82F2G7BL4E | DOXORUBICIN HYDROCHLORIDE | 25316-40-9 | DOXORUBICIN HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 0069-1442-04 | 00069144204 | 1 VIAL, MULTI-DOSE in 1 CARTON (0069-1442-04) / 100 mL in 1 VIAL, MULTI-DOSE | 2024-10-14 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | 2026-04-30 | HUMAN PRESCRIPTION DRUG LABEL | 14 |
| Doxorubicin Hydrochloride | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | 2023-05-04 | HUMAN PRESCRIPTION DRUG LABEL | 11 |